title: Gabapentin or amitriptyline for painful diabetic neuropathy?
authors.affiliation: Pharmacy Program, University of Toronto.
authors.forename: T
authors.initials: T
authors.lastname: Rawn
authors.forename: C
authors.initials: C
authors.lastname: Papoushek
authors.forename: M F
authors.initials: MF
authors.lastname: Evans
mesh_terms: D000085:Acetates / Q000627:therapeutic use*; D000588:Amines; D000639:Amitriptyline / Q000627:therapeutic use*; D000700:Analgesics / Q000627:therapeutic use*; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000473:pathology; D005194:Family Practice; D000077206:Gabapentin; D006801:Humans; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid
chemical_list: D000085:Acetates; D000588:Amines; D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D003509:Cyclohexanecarboxylic Acids; D000639:Amitriptyline; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin